CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Hôpital Albert-Chenevier - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/healthcare

healthcare organization

Hôpital Albert-Chenevier

FR

OPENALEX: I4210156254↗ROR: 0511th722↗

People

Connected researchers

Andreı̈ SzökeORCID 0000-0003-2973-7981 Antonio LasalviaORCID 0000-0001-9963-6081 Baptiste PignonORCID 0000-0003-0526-3136 Bruno ÉtainORCID 0000-0002-5377-1488 Franck SchürhoffORCID 0000-0002-2732-406X Marion LEBOYERORCID 0000-0001-5473-3697

Public evidence

2 connected articles

Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.2023 · Europe PMC Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.2021 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.